Rationale and benefit of using high throughput solubility screens in drug discovery

Drug Discovery Today: Technologies

Volumn 3, Issue 1, 2006, Pages 67-71

  Goodwin, Joseph J ^a  

^a BD BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; DRUG; ORGANIC SOLVENT;

AQUEOUS SOLUTION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG INDUSTRY; DRUG METABOLISM; DRUG RESEARCH; DRUG SCREENING; DRUG SOLUBILITY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; LIGHT ABSORPTION; NEPHELOMETRY; PHASE SEPARATION; PHYSICAL CHEMISTRY; POWDER; PRECIPITATION; REVIEW; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 33646115662     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2005.03.001     Document Type: Review

References (21)

1. Kerns E.H. High throughput physicochemical profiling for drug discovery. J. Pharm. Sci. 90 (2001) 1838-1858
2. Caldwell G.W., et al. The new preclinical paradigm: compound optimization in late phase drug discovery. Curr. Top. Med. Chem. 1 (2001) 353-366
3. Di L., and Kerns E.H. Profiling drug like properties in discovery research. Curr. Opin. Chem. Biol. 7 (2003) 402-408
4. Avdeef A. Physicochemical profiling (solubility, permeability, and charge state). Curr. Top. Med. Chem. 1 (2001) 227-351
5. Lipinski C.A. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (2001) 3-26
6. Hendriksen B.A., et al. The composite solubility versus pH profile and its role in intestinal absorption prediction. AAPS Pharm. Sci. 5 (2003) 1-15
7. Kibbey C.E., et al. An integrated process for measuring the physicochemical properties of drug candidates in a preclinical discovery environment. J. Pharm. Sci. 90 (2001) 1164-1175
8. Yalkowsky S.H., and Valvani S.C. Solubility and partitioning I: solubility of nonelectrolytes in water. J. Pharm. Sci. 69 (1980) 912-922
9. Glomme A., et al. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J. Pharm. Sci. 94 (2004) 1-16
10. Chen X.Q., and Venkatesh S. Miniature device for aqueous and nonaqueous solubility measurements during drug discovery. Pharm. Res. 21 (2004) 1758-1761
11. Huang L.F., and Tong W.Q. Impact of solid state properties on developability assessment of drug candidates. Adv. Drug Deliv. Rev. 56 (2004) 321-334
12. Hancock B.C., and Parks M. What is the true solubility advantage for amorphous pharmaceuticals?. Pharm. Res. 17 (2000) 397-404
13. Bevan C.D. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal. Chem. 72 (2000) 1781-1787
14. Goodwin, J. et al. (1999) A new rapid technique for sensitive solubility measurements: a flow cytometric approach. 5th Annual Society for Biomolecular Screening (SBS) Conference, 13-16 September, Edinburg
15. Pan L., et al. Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J. Pharm. Sci. 90 (2000) 521-529
16. Kibbey C.E., et al. An integrated process for measuring the physiochemical properties of drug candidates in a preclinical discovery environment. J. Pharm. Sci. 90 (2001) 1164-1175
17. Pitt A. High-throughput screening to determine aqueous drug solubility. Pharm. Discov. (2005) 46-49
18. Roy D., et al. Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay. Drug Dev. Ind. Pharm. 27 (2001) 107-109
19. Feng B.Y., et al. High-throughput assays for promiscuous inhibitors. Nat. Chem. Biol. 1 (2005) 146-148
20. Seidler J., et al. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 46 (2003) 4477-4486
21. Frenkel Y.V., et al. Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. J. Med. Chem. 48 (2005) 1974-1983